Incremental costs, QALYs and cost-effectiveness: Phase 3 vs phase 2 regimen for 1,000 patients; 1, 5, 10, and 30-year analytic time horizons for 1,000 patients.
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Incremental costs, QALYs and cost-effectiveness: Phase 3 vs phase 2 regimen for 1,000 patients; 1, 5, 10, and 30-year analytic time horizons for 1,000 patients.
创建时间：
2022-02-25
